Home > Insider Trading > Filing (0001209191-19-054166)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1087294	Cumberland Pharmaceuticals Inc	CPIX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1075050	J A Kazimi	2525 West End Ave. Suite 950 Nashville TN 37203	Chairman And Ceo	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2019-09-20	60	$5.33	5,766,502	No	4	P	Direct
Common Stock	Acquisiton	2019-09-23	60	$5.35	5,766,562	No	4	P	Direct
Common Stock	Acquisiton	2019-09-24	60	$5.39	5,766,622	No	4	P	Direct
Common Stock	Acquisiton	2019-09-25	60	$5.38	5,766,682	No	4	P	Direct
Common Stock	Acquisiton	2019-09-26	60	$5.76	5,766,742	No	4	P	Direct
Common Stock	Acquisiton	2019-09-27	60	$5.76	5,766,802	No	4	P	Direct
Common Stock	Acquisiton	2019-09-30	60	$5.89	5,766,862	No	4	P	Direct
Common Stock	Acquisiton	2019-10-01	60	$5.89	5,766,922	No	4	P	Direct
Common Stock	Acquisiton	2019-10-02	60	$5.77	5,766,982	No	4	P	Direct
Common Stock	Acquisiton	2019-10-04	60	$5.76	5,767,042	No	4	P	Direct
Common Stock	Acquisiton	2019-10-07	60	$5.74	5,767,102	No	4	P	Direct
Common Stock	Acquisiton	2019-10-08	60	$5.81	5,767,162	No	4	P	Direct
Common Stock	Acquisiton	2019-10-09	60	$5.78	5,767,222	No	4	P	Direct
Common Stock	Acquisiton	2019-10-10	60	$5.86	5,767,282	No	4	P	Direct
Common Stock	Acquisiton	2019-10-11	60	$5.71	5,767,342	No	4	P	Direct
Common Stock	Acquisiton	2019-10-14	60	$5.67	5,767,402	No	4	P	Direct
Common Stock	Acquisiton	2019-10-15	60	$5.63	5,767,462	No	4	P	Direct
Common Stock	Acquisiton	2019-10-16	60	$5.56	5,767,522	No	4	P	Direct
Common Stock	Acquisiton	2019-10-17	60	$5.52	5,767,582	No	4	P	Direct
Common Stock	Acquisiton	2019-10-18	34	$5.45	5,767,616	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019.